FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100409 [Registered on: 06/01/2026] Trial Registered Prospectively
Last Modified On: 06/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Study of infection nerve and blood vessel status blood sugar control and wound severity in hospitalized patients with diabetic foot ulcers 
Scientific Title of Study   A clinical microbiological neurovascular and glycemic control study in diabetic foot ulcer and its correlation with severity of Wagner grading in hospitalized patients 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mahalakshmi Subramani 
Designation  Postgraduate 
Affiliation  Vinayaka missions kirupananda variyar medical college and hospitals salem  
Address  Department of general medicine Vinayaka missions kirupananda variar medical college and hospital salem

Salem
TAMIL NADU
636308
India 
Phone  9787730841  
Fax    
Email  mahasubramani9081@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kirubhakaran  
Designation  Professor  
Affiliation  Vinayaka missions kirupananda variar medical college and hospital salem  
Address  Department of general medicine Vinayaka missions kirupananda variar medical college and hospital salem

Salem
TAMIL NADU
636308
India 
Phone  9786876687  
Fax    
Email  dr.kirubhakaranoffice@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mahalakshmi Subramani 
Designation  Postgraduate 
Affiliation  Vinayaka missions kirupananda variyar medical college and hospitals salem  
Address  Department of general medicine Vinayaka missions kirupananda variar medical college and hospital salem

Salem
TAMIL NADU
636308
India 
Phone  9787730841  
Fax    
Email  mahasubramani9081@gmail.com  
 
Source of Monetary or Material Support  
Vinayaka missions kirupananda variyar medical college and hospitals salem 636308 Tamilnadu India  
 
Primary Sponsor  
Name  Dr Mahalakshmi Subramani 
Address  Department of general medicine Vinayaka missions kirupananda variyar medical college and hospitals salem 636308 Tamilnadu India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mahalakshmi Subramani  Vinayaka missions kirupananda variyar medical college and hospitals salem   Opd no 16 Department of general medicine Vinayaka missions kirupananda variyar medical college and hospitals salem
Salem
TAMIL NADU 
9787730841

mahasubramani9081@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Vinayaka missions kirupananda variyar medical college and hospitals Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E114||Type 2 diabetes mellitus with neurological complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients diagnosed with Type 2 Diabetes Mellitus
Hospitalized patients with one or more clinically diagnosed diabetic foot ulcers
Age more than or equal to 30 years
Ulcers that can be graded using the Wagner classification system
Patients who give informed consent to participate in the study
Willingness to undergo clinical microbiological Retinal Renal and neurovascular assessment 
 
ExclusionCriteria 
Details  Patients with non-diabetic foot ulcers example venous pressure or arterial ulcers unrelated to diabetes
Patients with malignant ulcers or ulcers secondary to autoimmune or vasculitic diseases
Individuals with severe comorbid conditions such as advanced malignancy end-stage renal disease on dialysis or terminal illness that could confound outcomes
Pregnant or lactating women
Patients who have received antibiotic treatment within the past 7 days before wound culture collection
Patients with incomplete clinical data or who are unable/unwilling to comply with study protocols
Patient with Type 1 Diabetes Mellitus 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
This study is expected to demonstrate a strong correlation between Wagner grades and clinical microbiological neurovascular and metabolic findings in diabetic foot ulcers
Higher grades are anticipated to be associated with severe neuropathy poor vascular status and complex often resistant infections
Incorporating nephropathy retinopathy and glycemic control enhances prognostic accuracy
The findings aim to validate the Wagner system as a predictive tool for DFU severity support early identification of high risk patients and guide targeted treatment to reduce complications and hospital stays 
18 months 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   19/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Diabetic foot ulcer is a common and serious complication of diabetes mellitus often leading to infection prolonged hospitalization and risk of limb loss 
The severity of diabetic foot ulcers is commonly assessed using the Wagner grading system which helps guide management and prognosis
This study aims to evaluate the clinical features microbiological profile neurovascular status and level of glycemic control in hospitalized patients with diabetic foot ulcers and to correlate these factors with the severity of ulcers based on Wagner grading 
Clinical assessment will include ulcer characteristics and associated comorbidities Microbiological evaluation will identify causative organisms and infection patterns
Neurovascular assessment will focus on peripheral neuropathy and peripheral arterial disease 
Glycemic control will be assessed using blood glucose levels and HbA1c values
By correlating these parameters with Wagner grades the study seeks to identify factors associated with more severe ulcers 
The findings may help in early risk stratification targeted treatment and improved prevention of complications such as infection and amputation in diabetic foot ulcer patients
 
Close